← Back
Data updated: Mar 10, 2026
HBT LABS INC
Oncology
HBT LABS INC is a generic drug manufacturer focused on Oncology. Key products include FULVESTRANT.
2019
Since
1
Drugs
-
Trials
12
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
FULVESTRANT 2025-11-21
Labeling
FULVESTRANT 2025-09-17
Labeling
FULVESTRANT 2024-12-04
Labeling
FULVESTRANT 2024-12-04
Labeling
FULVESTRANT 2024-12-04
Labeling
FULVESTRANT 2024-12-04
Labeling
FULVESTRANT 2024-03-21
Labeling
FULVESTRANT 2024-03-21
Labeling
FULVESTRANT 2024-03-21
Labeling
FULVESTRANT 2024-03-21
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2019-11-21
- Latest
- 2021-05-28
- Applications
- 1